HomeGRAIL (GRAL) Market Cap

GRAIL (GRAL) Market Cap

Track the latest market capitalisation and see how the company's value has changed over time.

GRAIL's market cap September 2026

As of 07 September 2026, GRAIL's market cap was $3.13B

This places GRAIL among the largest companies by market capitalisation.

Market cap (market capitalisation) is the total value of a company's shares on the stock market – calculated by multiplying the number of outstanding shares by its current share price.

Fiscal year-end GRAL market cap

As of 2024, GRAIL's market capitalisation was $599.77M. Historical data for previous fiscal years is not yet available.

Market capitalisation of similar companies

The table below shows other leading companies in the same sector include United Therapeutics, Agenus, Prothena Corp, and Ginkgo Bioworks.

Name	Market Capitalization
United Therapeutics	$21.00B
Agenus	$279.88M
Prothena Corp	$527.00M
Ginkgo Bioworks	$418.16M

Data is sourced from public company disclosures, including SEC filings and EDGAR. It is provided for informational purposes only and does not constitute investment advice or a recommendation to trade. Figures are believed to be accurate at the stated dates but may change without notice.

Past performance is not a reliable indicator of future results. Share prices are indicative and may differ from live market prices.

FAQ

What is GRAIL's current market cap?

As of 07 September 2026, GRAIL's market capitalisation is approximately $3.13B. However, it's important to note that market cap values fluctuate daily based on share price movements.

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.